NPC in Morning Consult: “Why Is Drug Spending So High?” Is the Wrong Question

In a column published in Morning Consult, NPC Chief Science Officer and Executive Vice President Robert W. Dubois, MD, PhD, explains that asking why drug spending is so high assumes that spending more money on drugs is a bad thing, confusing drug spending with overall health care spending.

In a column published today in Morning Consult, National Pharmaceutical Council Chief Science Officer and Executive Vice President Robert W. Dubois, MD, PhD, explains that asking why drug spending is so high assumes that spending more money on drugs is a bad thing, confusing drug spending with overall health care spending. Our pressing question should not be, “Why is drug spending so high?” but rather, “How can we best spend our health care dollars to benefit patients?”

>> Read the rest of Dr. Dubois' commentary in Morning Consult


NPC recently launched Going Below the Surface, a research-first endeavor dedicated to unearthing and examining the drivers of health care spending in the United States, and convening a multiple-stakeholder discussion to better understand what we receive for these investments. Learn more and join the conversation at GoingBelowtheSurface.org or via social media by following @npcnow and using #GoingBelowTheSurface.